Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Roivant Sciences
Over the past year ALNY returned −63.8% and ROIV returned +84.6%; their daily moves had a correlation of 0.02.
ALNY −63.8% ROIV +84.6%Growth of $1, one year, split-adjusted
| Metric | ALNY | ROIV |
|---|---|---|
| Price | $165.00 | $36.91 |
| Market cap | $22.10B | $26.66B |
| Today | −5.17% | −1.63% |
| 1 month | −28.6% | +4.0% |
| 6 months | −44.3% | +32.6% |
| Year to date | −58.5% | +70.1% |
| 1 year | −65.7% | +96.7% |
| Revenue growth (YoY) | +16.7% | −33.5% |
| Gross margin | 75.2% | 100.0% |
| Net margin | 148.6% | −13164.8% |
| P/E (TTM) | 8.1× | — |
| Price / sales | 4.4× | 3,539.7× |
| Net cash | $2.57B | $3.84B |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 49.2% |
| Short % of float | 4.9% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).